CrossrefInfokarte
Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Comparative Effectiveness Research · 2015
DOI: 10.2147/cer.s62090 ↗Abstract
Kein Abstract verfügbar.
EUVIMED